ILiAD Biotechnologies Receives NIH Grant to Develop Novel Tuberculosis Vaccine using proprietary B-Tech Vector Platform streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
· New milestone for NeuroLead, the active agent screening platform · New publications in scientific journals · Start of Phase I/II clinical trial for Batten disease
Lyon, 28 February 2022 -